Women’s health company Organon is selling off its postpartum uterine bleeding or hemorrhage system to Laborie Medical ...
News-Medical.Net on MSN
Studies uncover two novel, critical strategies for bacterial surface movement
New studies from Arizona State University reveal surprising ways bacteria can move without their flagella - the slender, whip ...
For patients like Pham, Vantive’s home dialysis technologies represent more than medical equipment — they’re a pathway to a ...
"It was a very big wake-up call," Jordan Kruse told The Post. "Life was structured a lot differently than what we expected it ...
More than 1 in 10 Utahns relies on the Affordable Care Act marketplace for health coverage. For many of them, the cost will ...
Once a UTI develops, “the most common and effective treatment is a course of antibiotics,” says Adair. The specific ...
Health care fraud enforcement remains a top priority of the Trump administration, warns a law firm specializing in False ...
StockStory.org on MSN
LMAT Q3 Deep Dive: Pricing and Margin Expansion Offset by Cautious Growth Outlook
Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million. Next quarter’s revenue guidance of ...
The Punch on MSN
Kidney disease shattered my life ambitions— 22-year-old patient
At just 22, Margaret Agbo is locked in a life-and-death battle after being diagnosed with kidney disease in 2024. Speaking to AYOOLA OLASUPO, she opens up ...
2hon MSN
Triumph of surgery: Delhi doctors save boy with rare artery disease after years of heart failure
A 12-year-old boy from Vrindavan, battling a rare inflammatory disease that severely impacted his heart and kidneys, has been ...
CFO McMillan noted, “Your comp is kind of progressing towards the 21% range plan of 4% to 5% faster than expected,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results